Share review of Pembrolizumab (Keytruda)

Pembrolizumab (Keytruda) 2019-05-17 Person 4 5 0

I have just had my 20th session of immunotherapy. 14 months ago I was very weak and suffering from pneumonia, it was at this time that I was diagnosed with stage 4 lung cancer. I feel that at the age of 76 I was very lucky to be offered immunotherapy and have not looked back since my first session, am now feeling pretty good except very short of breath and a bit of itching, small price to pay for 14 months of life.